SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-127657
Filing Date
2024-05-01
Accepted
2024-05-01 17:25:31
Documents
20
Period of Report
2024-05-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d811393d8k.htm   iXBRL 8-K 37251
2 EX-1.1 d811393dex11.htm EX-1.1 285468
3 EX-4.1 d811393dex41.htm EX-4.1 88696
4 EX-5.1 d811393dex51.htm EX-5.1 16568
5 EX-99.1 d811393dex991.htm EX-99.1 9884
9 GRAPHIC g811393g0501072250284.jpg GRAPHIC 1649
10 GRAPHIC g811393g0501073606895.jpg GRAPHIC 5840
11 GRAPHIC g811393g0501073607220.jpg GRAPHIC 1649
  Complete submission text file 0001193125-24-127657.txt   694613

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA alrn-20240501.xsd EX-101.SCH 2855
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE alrn-20240501_lab.xml EX-101.LAB 18756
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alrn-20240501_pre.xml EX-101.PRE 11713
24 EXTRACTED XBRL INSTANCE DOCUMENT d811393d8k_htm.xml XML 3808
Mailing Address 12407 N. MOPAC EXPY. SUITE 250 #390 AUSTIN TX 78758
Business Address 12407 N. MOPAC EXPY. SUITE 250 #390 AUSTIN TX 78758 7378021989
Aileron Therapeutics, Inc. (Filer) CIK: 0001420565 (see all company filings)

IRS No.: 134196017 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38130 | Film No.: 24904216
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)